ORIC Pharmaceuticals Inc

ORICNASDAQ · USD
13.47USD0.00 (+0.75%)
3210

ORIC Pharmaceuticals Inc (ORIC) Unusual Options Activity Today

ORIC options volume power reached 503.33x on the previous trading day. The highest reading was on the $14 CALL expiring 2026-11-20.

Read more

Checking ORIC unusual options activity helps you spot when traders are making outsized bets on ORIC Pharmaceuticals Inc before the broader market catches on. ORIC Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ORIC unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ORIC unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ORIC unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ORIC unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations.

The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Catalysts rarely arrive without a footprint, and ORIC unusual options activity is often where that footprint shows up first. Our scanner tracks ORIC Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ORIC unusual options volume on the call side or chasing put sweeps, ORIC Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
15.000.451.400.93133%124129.27%
5.006.5011.008.75368%00—
6.005.5010.007.75308%00—
7.005.609.007.30378%00—
8.003.507.605.55152%00—
Puts
5.00—4.904.901,000%00—
6.00—4.904.901,000%00—
7.00—4.904.901,000%00—
8.00—4.904.90993%00—
9.00—4.904.90853%020.00%

As of September 30, 2026

Spot unusual options activity before it moves

Track ORIC options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial